Lee Ainslie Rocket Pharmaceuticals, Inc. Transaction History

Maverick Capital LTD

$5.84 Billion
Q2 2025

A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 8,363,813 shares of RCKT stock, worth $24.3 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

8,363,813

Previous 5,199,218 60.87%

Holding current value

$24.3 Million

Previous $34.7 Million 40.91%

% of portfolio

0.35%

Previous 0.68%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.33 - $8.01 $7.37 Million - $25.3 Million	3,164,595 Added 60.87%	8,363,813 $20.5 Million
Q1 2025 May 15, 2025	BUY	$6.67 - $12.72 $2,121 - $4,044	318 Added 0.01%	5,199,218 $34.7 Million
Q4 2024 Feb 14, 2025	BUY	$11.35 - $18.82 $12.3 Million - $20.3 Million	1,080,228 Added 26.23%	5,198,900 $65.4 Million
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $3.35 Million - $4.93 Million	190,360 Added 4.85%	4,118,672 $76.1 Million
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $826,400 - $1.07 Million	40,000 Added 1.03%	3,928,312 $84.6 Million
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $3.81 Million - $4.48 Million	-145,756 Reduced 3.61%	3,888,312 $105 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $26.8 Million - $51 Million	-1,595,902 Reduced 28.35%	4,034,068 $121 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $18.8 Million - $30.1 Million	1,250,000 Added 28.54%	5,629,970 $115 Million
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $458,763 - $652,610	-27,653 Reduced 0.63%	4,379,970 $87 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $16 Million - $22.9 Million	1,011,805 Added 29.8%	4,407,623 $75.5 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $13.4 Million - $19.7 Million	863,452 Added 34.1%	3,395,818 $66.5 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $3.18 Million - $6.64 Million	399,200 Added 18.71%	2,532,366 $34.8 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $3.13 Million - $5.64 Million	238,200 Added 12.57%	2,133,166 $33.8 Million
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $5.05 Million - $8.46 Million	234,850 Added 14.15%	1,894,966 $41.4 Million
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $40.8 Million - $72.8 Million	1,486,229 Added 854.71%	1,660,116 $49.6 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $6.85 Million - $8.22 Million	173,887 New	173,887 $7.7 Million

Others Institutions Holding RCKT

# of Institutions

220

Shares Held

98.3M

Call Options Held

611K

Put Options Held

487K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $220M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track Lee Ainslie's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Account